$4.07 Billion Annual Boost: New Report Reveals High Return from Australian Medical Research Institutes
A new report commissioned by the Association of Australian Medical Research Institutes (AAMRI) and prepared by Nous Group reveals that the nation's medical research institutes contribute $4.07 billion annually to the economy.
Economic Impact and Return on Investment
The analysis provides a clear picture of the sector's financial value:
- Total annual economic benefit: $4.07 billion
- Overall return on investment: $3.90 for every $1 invested
- Return on investment for clinical trials: $5.80 per $1 invested
"The analysis identifies a return of $3.90 for every dollar invested overall, with clinical trials yielding a return of $5.80 per dollar invested."
The report also notes that clinical trials provide patients with early access to potential treatments.
Role and Collaboration
According to the analysis, medical research institutes operate within Australia's health and innovation ecosystem. They collaborate with hospitals, universities, and industry partners to support clinical trials, translate research discoveries into clinical practice, and develop new therapies and technologies.
National Strategies and Recognition
The report references national strategies, including the Ambitious Australia plan and the National Health and Medical Research Strategy, which recognize research and development as important for productivity, economic growth, and improved health outcomes.
Funding and Sustainability Challenges
Despite the strong returns, the report identifies a significant funding model pressure. While government funding covers direct research costs, significant indirect costs—such as infrastructure, equipment, data systems, and specialist staff—receive only partial funding.
As a result, institutes report relying on philanthropy, commercial activities, and internal reserves to cover these gaps.
"The analysis warns that without funding reform, some institutes may face financial sustainability challenges in the next decade, potentially affecting Australia's research capacity and future health and economic benefits."
Statements from AAMRI Representatives
AAMRI President Professor Jason Kovacic stated that the institutes are a national asset connecting scientific discovery with patient care. He noted that their model integrates clinicians, scientists, and patients to move research into clinical practice, improving patient outcomes and fostering economic growth.
AAMRI Chief Executive Dr Saraid Billiards stated that the sector creates skilled jobs, advances biotechnology and medical technology industries, and enhances Australia's global research standing. She emphasized that the institutes' independence and hospital connections enable research in patient care.
Professor Kovacic concluded that appropriate policy settings would maintain medical research institutes as a high-return investment.
HMRI Institute Director Professor Francey Kay also commented on local impact, though specific details were not provided in the report.